Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Current Period Unaudited)

v3.22.2.2
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jul. 31, 2022
Oct. 31, 2021
Current assets:    
Cash and cash equivalents $ 2,445 $ 9,298
Trade receivables, net 58,815 49,034
Inventory 5,006 4,902
Income taxes receivable 391 275
Prepaid expenses and other current assets 5,678 4,110
Total current assets 72,335 67,619
Property, plant and equipment, net 385,247 337,771
Intangible assets, net 141,467 158,539
Goodwill 221,615 224,700
Other non-current assets 1,975 2,168
Deferred financing costs 1,829 1,868
Total assets 824,468 792,665
Current liabilities:    
Revolving loan 16,884 990
Current portion of capital lease obligations 108 103
Accounts payable 9,063 10,706
Accrued payroll and payroll expenses 9,334 12,226
Accrued expenses and other current liabilities 35,998 23,940
Income taxes payable 219 274
Total current liabilities 71,606 48,239
Long term debt, net of discount for deferred financing costs 370,128 369,084
Capital lease obligations, less current portion 196 278
Deferred income taxes 72,182 70,566
Warrant liability 7,030 16,923
Total liabilities 521,142 505,090
Commitments and Contingencies (see Note 13)
Zero-dividend convertible perpetual preferred stock, $0.0001 par value, 2,450,980 shares issued and outstanding as of July 31, 2022 and October 31, 2021 25,000 25,000
Stockholders' equity    
Common stock, $0.0001 par value, 500,000,000 shares authorized, 56,599,833 and 56,564,642 issued and outstanding as of July 31, 2022 and October 31, 2021, respectively 6 6
Additional paid-in capital 378,481 374,272
Treasury stock (1,856) (461)
Accumulated other comprehensive income (loss) (5,056) 3,671
Accumulated deficit (93,249) (114,913)
Total stockholders' equity 278,326 262,575
Total liabilities and stockholders' equity $ 824,468 $ 792,665